Last $27.22 USD
Change Today +0.01 / 0.04%
Volume 221.4K
MDCO On Other Exchanges
Symbol
Exchange
Munich
NASDAQ GS
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Clive A. Meanwell M.D., Ph.D.

Chairman and Chief Executive Officer, The Medicines Company
AgeTotal Calculated CompensationThis person is connected to 20 board members in 4 different organizations across 6 different industries.

See Board Relationships
56$4,575,571
As of Fiscal Year 2013

Background*

Dr. Clive A. Meanwell, M.D., Ph.D. has been the Chief Executive Officer of The Medicines Company since February 2012. Dr. Meanwell served as President of The Medicines Company since October 2009 and served as its Chief Executive Officer from August 2004 to December 2004. Dr. Meanwell served as the President of Targanta Therapeutics Corp. since February 25, 2009. Dr. Meanwell served as Co-Chief Executive Officer and President of Medicines Company from 1996 to September ...

Read Full Background

Corporate Headquarters*

8 Sylvan Way
Parsippany, New Jersey 07054

United States

Phone: 973-290-6000
Fax: 973-656-9898

Board Members Memberships*

Director
Director
1996-Present
Chairman and Chief Executive Officer
2003-2010
Former Independent Director and Member of Nominating & Governance Committee
2003-Present
Director and Member of Nominating & Governance Committee
2004-Present
Vice Chairman, Chairman of Nomination & Remuneration Committee and Member of Audit Committee
2009-N/A
Former President, Director, Chairman of The Medicines Company and Chief Executive Officer of The Medicines Company

Education*

Unknown/Other Education
University of Birmingham
PhD
University of Birmingham
MD
University of Birmingham

Other Affiliations*

Annual Compensation*

Salary$793,272
Total Annual Compensation$793,272

Stock Options*

Restricted Stock Awards$2,057,997
All Other Compensation$3,354
Exercised Options125,000
Exercised Options Value$1,086,433
Exercisable Options874,897
Exercisable Options Value$16,001,392
Unexercisable Options206,211
Unexercisable Options Value$3,281,347
Total Value of Options$20,369,171
Total Number of Options1,206,108

Total Compensation*

Total Annual Cash Compensation$1,639,478
Total Short Term Compensation$793,272
Other Long Term Compensation$2,061,351
Total Calculated Compensation$4,575,571
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDCO:US $27.22 USD +0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Steven G. Anderson Founder, Chairman, Chief Executive Officer and President
CryoLife Inc.
$743.7K
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Albert D. Friesen Ph.D.Founder, Chairman and Chief Executive Officer
Medicure Inc.
C$180.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICINES COMPANY, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.